DC excipient

What is PROSOLV® RX 90? PROSOLV® RX 90 was developed using JRS PHARMA‘s proven PROSOLV® Technology and was the first...

What is PROSOLV® RX 90? PROSOLV® RX 90 was developed using JRS PHARMA‘s proven PROSOLV® Technology and was the first...

What is PROSOLV® RX 90? PROSOLV® RX 90 was developed using JRS PHARMA‘s proven PROSOLV® Technology and was the first...

Introduction Pharmaceutical lactose by Amor Pharma is a cornerstone in both the pharmaceutical and food industries, valued for its versatility...

Streamline Your R&D and Production Introduction The health science industry faces a wide variety of challenges including increased pressure to:...

Abstract Material-sparing tablet development (MSTD) describes an approach to tablet formulation development that uses the active pharmaceutical ingredient's (API) material...

Abstract Improving the manufacturability of drug formulations via direct compression has been of great interest for the pharmaceutical industry. Selecting...

MicroceLac® Plus The new co-processed Excipient for Direct Compression (DC) What’s new? What’s special? MicroceLac® Plus is an innovative addition...

Abstract 3D printing (3DP) plays a crucial role in accelerating formulation processes and significantly reduces the time needed to transition...

Abstract The flowability and compressibility of powders during tableting are crucial for determining the quality of pharmaceutical products. Although silicon...